RTW Investments’s SAB Biotherapeutics SABS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-635,276
Closed -$1.72M 75
2024
Q3
$1.72M Sell
635,276
-131,670
-17% -$356K 0.02% 64
2024
Q2
$2.38M Sell
766,946
-150,881
-16% -$468K 0.04% 62
2024
Q1
$4.17M Sell
917,827
-1
-0% -$5 0.06% 64
2023
Q4
$6.31M Buy
+917,828
New +$6.31M 0.1% 57